Published on
08:30 GMT
FDA Approves PIMJETMI® (pimicotinib) for Patients with Tenosynovial Giant Cell Tumor
BOSTON--(BUSINESS WIRE)--Nov 10, 2026-- EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the US and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved PIMJETMI ® (pimicotinib), a once-daily oral …
Source:
Rutland Herald - Vermont
-
Center-left
